Fibulin-4 was decreased in endometrial carcinoma tissues, and loss of fibulin-4 expression was significantly related with poor differentiation, lymph node metastasis, and poor prognosis of endometrial carcinoma. The gene discussed is EFEMP2; the disease is metastatic malignant neoplasm in the lymph nodes.